[]
Ueda M., Kusunoki S.: Autoimmune Neuropathies: Diagnosis, Treatment,
and Recent Topics. Brain Nerve 2011; 63: 549–555.
[]
Zhang G., Lehmann H.C., Manoharan S., et al.: Anti-ganglioside antibodymediated
activation of RhoA induces inhibition of neurite outgrowth. J
Neurosci 2011; 31: 1664–1675.
[]
Torricelli E. R.: Guillain Barré syndrome in pediatrics Medicina, 2009; 69:
84–89.
[]
McGrogan A., Madle G.C., Seaman H.E., et al.: The epidemiology of
Guillain-Barré syndrome worldwide. A systematic literature review.
Neuroepidemiology 2009; 32: 150–163.
[]
Korinthenberg R., Schessl J., Kirschner J.: Clinical presentation and
course of childhood Guillain-Barré syndrome: a prospective multicentre
study. Neuropediatrics 2007; 38: 10–17.
[]
Ramírez-Zamora M., Burgos-Ganuza C.R., Alas-Valle D.A., et al.: Guillain-
Barre syndrome in the paediatric age: epidemiological, clinical and
therapeutic profile in a hospital in El Salvador. Rev Neurol 2009; 48:
292–296.
[]
Kroczka S., Steczkowska M., Kaciński M.: Przydatność badania EMG jako
wskaźnika dla dalszych badań w chorobach nerwowo-mięśniowych.
Przegl Lek 2009; 66: 913–919.
[]
Gupta D., Nair M., Baheti N.N., et al.: Electrodiagnostic and clinical
aspects of Guillain-Barré syndrome: an analysis of 142 cases. J Clin
Neuromuscul Dis 2008; 10: 42–51.
[]
Mizuguchi K., Hoshino H., Abe Y., et al.: Early and serial electrodiagnostic
findings in childhood Guillain-Barré syndrome. No To Hattatsu. 2008; 40:
460–464.
[]
Kalita J., Misra U.K., Das M.: Neurophysiological criteria in the diagnosis
of different clinical types of Guillain-Barre syndrome. J Neurol Neurosurg
Psychiatry 2008; 79: 289–293.
[]
Gordon P.H., Wilbourn A.J.: Early electrodiagnostic findings in Guillain-
Barré syndrome. Arch Neurol 2001; 58: 913–917.
[]
Aminoff MJ.: Use of somatosensory evoked potentials to evaluate the
peripheral nervous system. J Clin Neurophysiol 1987; 4: 135–144.
[]
Albers J.W, Donofrio P.D, McGonagle T.K.: Sequential
electrodiagnostic abnormalities in acute inflammatory demyelinating
polyradiculoneuropathy. Muscle Nerve 1985; 8: 528–539.
[]
Albers J.W, Kelly J.J Jr.: Acquired inflammatory demyelinating
polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve
1989 ;12: 435–451.
[]
Nuwer M.R., Aminoff M., Desmedt J., et al.: IFCN recommended
standards for short latency somatosensory evoked potentials. Report of
an IFCN committee. International Federation of Clinical Neurophysiology.
Electroencephalogr Clin Neurophysiol 1995; 94: 151–153.
[]
Taylor M.J., Fagan E.R.: SEPs to median nerve stimulation: normative
data for paediatrics. Electroencephalogr Clin Neurophysiol 1988; 71:
323–330.
[]
Kalra V., Sankhyan N., Sharma S., et al.: Outcome in childhood Guillain-
Barré syndrome. Indian J. Pediatr. 2009; 76: 795–799
[]
Kleyweg R.P., van der Meche F.G.A., Schmitz P.I.M.: Interobserver
agreement in the assessment of muscle strength and functional abilities
in Guillan-Barre syndrome. Muscle Nerve 1991; 14: 1103–1109.
[]
Merkies I.S.J., Schmitz P.I.M., van der Meche F.G.A., et al.:
Connecting impairment, disability, and handicap in immune mediated
polyneuropathies. J Neurol Neurosurg Psychiatry 2003; 74: 99–104.
[]
Merkies I.S.J., Schmitz P.I.M., van der Meche F.G.A., et al.: Psychometric
evaluation of a new sensory scale in immune-mediated polyneuropathies.
Neurology 2000; 54: 943–949.
[]
Merkies I.S.J., Schmitz P.I.M., van der Meche F.G.A., et al.: Clinimetric
evaluation of a new overall disability scale in immune mediated
polyneuropathies. J Neurol Neurosurg Psychiatry 2002; 72: 596–601.
[]
van Koningsveld R., W Steyerberg E., Hughes R., et al.: A clinical
prognostic scoring system for Guillain-Barré syndrome The Lancet
Neurology 2007; 6: 589–594.
[]
Kroczka S., Kaciński M., Steczkowska M.: Kliniczne i neurofizjologiczne
następstwa zespołu Guillain Barre. Przegl Lek 2011; 68: 1098.
[]
Ortiz Corredor F., Mieth Alviar K.W.: Prognostic factors for walking in
childhood Guillain-Barré syndrome. Rev Neurol 2003; 36: 1113–1120.
[]
Ortiz-Corredor F., Pena-Preciado M., Diaz-Ruiz J.: Motor recovery after
Guillain-Barre syndrome in childhood. Disabil Rehabil 2007; 29: 883–
889.
[]
Hung P.L., Chang W.N., Huang L.T., et al.: A clinical and electrophysiologic
survey of childhood Guillain-Barre syndrome. Pediatr Neurol 2004; 30:
86–91.
[]
Lee J.H., Sung I.Y., Rew I.S.: Clinical presentation and prognosis of
childhood Guillain-Barré syndrome. J. Paediatr. Child. Health 2008; 44:
449–454.
[]
Vajsar J., Taylor M.J., MacMillan L.J., et al.: Somatosensory evoked
potentials and nerve conduction studies in patients with Guillain-Barré
syndrome. Brain Dev 1992; 14: 315–318.
[]
Topçu M., Ergin M., Nurlu G., et al.: Evoked potentials in Guillain-Barré
syndrome. Turk J Pediatr 1993; 35: 79–85.
[]
Güngör L., Güngör I., Oztürk HE., et al.: Visual evoked potentials in
guillain-barré syndrome. J Clin Neurol 2011; 7: 34–39.
[]
Zgorzalewicz M., Zielińska M., Kilarski D.: Brain stem auditory and
visual evoked potentials in children and adolescents with Guillain-Barré
syndrome. Neurol Neurochir Pol 2004; 38 (1 Suppl 1): 31–37.
Scholar Google
PubMed